Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. QTI
QTI logo

QTI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy QT Imaging Holdings Inc (QTI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
6.040
1 Day change
2.90%
52 Week Range
7.350
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

QT Imaging Holdings Inc (QTI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, entry into new markets, and positive analyst sentiment outweigh the current financial losses. The technical indicators suggest a stable price trend, making it a suitable entry point for long-term investment.

Technical Analysis

The MACD is positive and contracting, indicating a potential upward trend. RSI is neutral at 40.686, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 6.065, and resistance is at 7.203. The stock has a 60% chance of gaining 11.72% in the next month.

Positive Catalysts

  • 877% YoY revenue growth in Q4

  • Entry into the UAE medical market with $24 million projected revenue from an exclusive distribution agreement.

  • Analyst coverage with a Buy rating and a $10 price target, highlighting the company's unique 3D imaging technology and potential in breast cancer screening.

Neutral/Negative Catalysts

  • Net income dropped to -$1.387 million in Q4 2025, showing significant losses.

  • EPS decreased to -0.1, indicating negative earnings per share.

  • Gross margin dropped to 37.97%, showing reduced profitability.

Financial Performance

In Q4 2025, revenue increased by 877.56% YoY to $8.28 million. However, net income dropped to -$1.387 million, EPS fell to -0.1, and gross margin decreased to 37.97%. Despite these losses, the company has shown significant revenue growth and optimistic guidance for 2026.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Lake Street initiated coverage with a Buy rating and a $10 price target, citing the company's innovative 3D imaging technology and its potential to become a significant modality in breast cancer screening.

Wall Street analysts forecast QTI stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast QTI stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 6.040
sliders
Low
0
Averages
0
High
0
0
Current: 6.040
sliders
Low
0
Averages
0
High
0
Lake Street
NULL
to
Buy
initiated
$10
AI Analysis
2026-01-30
Reason
Lake Street
Price Target
$10
AI Analysis
2026-01-30
initiated
NULL
to
Buy
Reason
Lake Street initiated coverage of QT Imaging with a Buy rating and $10 price target. The company's QT Scan delivers true 3D imaging of breast tissue and offers unique characteristics, making it highly attractive to patients and clinicians, the analyst tells investors. The "massive homerun opportunity" for QT is to become a significant modality within breast cancer screening, the analyst added.

People Also Watch